<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Goodrx Holdings Inc — News on 6ix</title>
<link>https://6ix.com/company/goodrx-holdings-inc</link>
<description>Latest news and press releases for Goodrx Holdings Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 17 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/goodrx-holdings-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835764578dffbe2df0f728c.webp</url>
<title>Goodrx Holdings Inc</title>
<link>https://6ix.com/company/goodrx-holdings-inc</link>
</image>
<item>
<title>GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-announces-date-for-first-quarter-2026-earnings-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-announces-date-for-first-quarter-2026-earnings-release-and-conference-call</guid>
<pubDate>Fri, 17 Apr 2026 20:05:00 GMT</pubDate>
<description>SANTA MONICA, Calif., April 17, 2026--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its first quarter 2026 financial results after U.S. markets close on Wednesday, May 6, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 7, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business out</description>
</item>
<item>
<title>GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-now-offers-access-to-wegovyr-hd-at-dollar399-per-month-self-pay-price</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-now-offers-access-to-wegovyr-hd-at-dollar399-per-month-self-pay-price</guid>
<pubDate>Wed, 15 Apr 2026 04:00:00 GMT</pubDate>
<description>Expands access to FDA-approved GLP-1 treatment with transparent pricing and integrated support through GoodRx for Weight Loss Brief Summary: Wegovy® HD is</description>
</item>
<item>
<title>GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-expands-access-to-eli-lilly-and-companys-new-oral-glp-1-foundayotm-and-zepboundr-kwikpenr-with-self-pay-pricing-at-more-than-70000-pharmacies-nationwide</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-expands-access-to-eli-lilly-and-companys-new-oral-glp-1-foundayotm-and-zepboundr-kwikpenr-with-self-pay-pricing-at-more-than-70000-pharmacies-nationwide</guid>
<pubDate>Thu, 09 Apr 2026 04:00:00 GMT</pubDate>
<description>Eligible self-pay consumers can access Foundayo starting at $149 per month through GoodRx Brief Summary: GoodRx is expanding access to the newly FDA-approved</description>
</item>
<item>
<title>GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-partners-with-viatris-to-offer-up-to-85percent-savings-on-established-brand-medications-9</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-partners-with-viatris-to-offer-up-to-85percent-savings-on-established-brand-medications-9</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>Collaboration expands access to trusted therapies with discounted cash prices for leading brands including Lipitor®, Celebrex®, Viagra®, and Norvasc® SANTA</description>
</item>
<item>
<title>GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-to-expand-employer-sponsored-access-to-zepboundr-kwikpenr-120</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-to-expand-employer-sponsored-access-to-zepboundr-kwikpenr-120</guid>
<pubDate>Fri, 06 Mar 2026 05:00:00 GMT</pubDate>
<description>GoodRx Employer Direct enables self-insured employers to subsidize the $449 Lilly Employer Connect medication price for Zepbound KwikPen to reduce employee</description>
</item>
<item>
<title>GoodRx Reports Fourth Quarter and Full Year 2025 Results</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-reports-fourth-quarter-and-full-year-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-reports-fourth-quarter-and-full-year-2025-results</guid>
<pubDate>Wed, 25 Feb 2026 05:00:00 GMT</pubDate>
<description>Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous Guidance Pharma Direct Revenue Beats Previous Outlook with Over</description>
</item>
<item>
<title>GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-expands-into-employer-market-with-launch-of-goodrx-employer-direct</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-expands-into-employer-market-with-launch-of-goodrx-employer-direct</guid>
<pubDate>Tue, 24 Feb 2026 05:00:00 GMT</pubDate>
<description>New program combines employer-subsidized discounted cash prices and custom telemedicine solutions with existing health benefits to close coverage gaps and</description>
</item>
<item>
<title>GoodRx Powers Pricing for Leading Brand Medications on TrumpRx</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-powers-pricing-leading-brand-medications-trumprx-2026-02-06</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-powers-pricing-leading-brand-medications-trumprx-2026-02-06</guid>
<pubDate>Thu, 05 Feb 2026 05:00:00 GMT</pubDate>
<description>Brief Summary: GoodRx is a core integration partner for TrumpRx, powering the pricing for leading brand medications At launch, GoodRx is the integrated</description>
</item>
<item>
<title>GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-earns-hitrust-i1-certification-second-consecutive-year-reinforcing-its</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-earns-hitrust-i1-certification-second-consecutive-year-reinforcing-its</guid>
<pubDate>Mon, 02 Feb 2026 05:00:00 GMT</pubDate>
<description>Independent assessment validates GoodRx’s continued leadership in cybersecurity and data protection SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx (Nasdaq:</description>
</item>
<item>
<title>60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/60-degrees-pharmaceuticals-expands-access-to-arakodar-with-goodrx-partnership</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/60-degrees-pharmaceuticals-expands-access-to-arakodar-with-goodrx-partnership</guid>
<pubDate>Mon, 02 Feb 2026 05:00:00 GMT</pubDate>
<description>GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine)Collaboration designed to lower patient out-of-pocket costs and expand the reach</description>
</item>
<item>
<title>GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-announces-date-fourth-quarter-210500271</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-announces-date-fourth-quarter-210500271</guid>
<pubDate>Wed, 28 Jan 2026 21:05:00 GMT</pubDate>
<description>SANTA MONICA, Calif., January 28, 2026--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full year 2025 financial results after U.S. markets close on Wednesday, February 25, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, February 26, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results a</description>
</item>
<item>
<title>Surescripts and GoodRx Partner to Advance Patient Price Transparency</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/surescripts-and-goodrx-partner-to-advance-patient-price-transparency</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/surescripts-and-goodrx-partner-to-advance-patient-price-transparency</guid>
<pubDate>Tue, 13 Jan 2026 05:00:00 GMT</pubDate>
<description>Surescripts Introduces New Patient Experience Solution to Transform the Medication Experience and Improve Patient Access, Affordability and Adherence</description>
</item>
<item>
<title>GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-launches-rxsmartsaver-giant-eagle-pharmacies-2026-01-08</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-launches-rxsmartsaver-giant-eagle-pharmacies-2026-01-08</guid>
<pubDate>Thu, 08 Jan 2026 05:00:00 GMT</pubDate>
<description>Program offers Giant Eagle customers instant access to meaningful savings on brand medications SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx (Nasdaq: GDRX),</description>
</item>
<item>
<title>GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-now-offers-novo-nordisks-cash-price-launch-wegovyr-pill-2026-01-05</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-now-offers-novo-nordisks-cash-price-launch-wegovyr-pill-2026-01-05</guid>
<pubDate>Mon, 05 Jan 2026 05:00:00 GMT</pubDate>
<description>Consumers can soon go to GoodRx for Weight Loss to determine eligibility and obtain a prescription for the first and only oral GLP-1 formulation SANTA</description>
</item>
<item>
<title>GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-participate-44th-annual-jp-morgan-healthcare-conference-2025-12-16</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-participate-44th-annual-jp-morgan-healthcare-conference-2025-12-16</guid>
<pubDate>Tue, 16 Dec 2025 05:00:00 GMT</pubDate>
<description>SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the</description>
</item>
<item>
<title>GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-launches-new-39-month-weight-loss-telemedicine-subscription-unveils-industry</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-launches-new-39-month-weight-loss-telemedicine-subscription-unveils-industry</guid>
<pubDate>Mon, 17 Nov 2025 05:00:00 GMT</pubDate>
<description>End-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment SANTA MONICA,</description>
</item>
<item>
<title>GoodRx Reports Third Quarter 2025 Results</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-reports-third-quarter-2025-results-2025-11-04</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-reports-third-quarter-2025-results-2025-11-04</guid>
<pubDate>Tue, 04 Nov 2025 05:00:00 GMT</pubDate>
<description>Company Maintains Full Year 2025 Revenue and Adjusted EBITDA Expectations; Raises Pharma Manufacturer Solutions Revenue Outlook to Approximately 35%</description>
</item>
<item>
<title>GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-launches-new-hair-loss-subscription-men-simplify-access-affordable-treatment</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-launches-new-hair-loss-subscription-men-simplify-access-affordable-treatment</guid>
<pubDate>Wed, 15 Oct 2025 04:00:00 GMT</pubDate>
<description>The all-in-one solution includes a virtual consultation, clinically proven prescription medication, and discreet home delivery, starting as low as $16/month</description>
</item>
<item>
<title>GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-announces-date-third-quarter-2025-earnings-release-and-conference-call-2025-10</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-announces-date-third-quarter-2025-earnings-release-and-conference-call-2025-10</guid>
<pubDate>Wed, 08 Oct 2025 04:00:00 GMT</pubDate>
<description>SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the</description>
</item>
<item>
<title>GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings</title>
<link>https://6ix.com/company/goodrx-holdings-inc/news/goodrx-expands-affordable-access-repathar-nearly-60-savings-2025-10-06</link>
<guid isPermaLink="true">https://6ix.com/company/goodrx-holdings-inc/news/goodrx-expands-affordable-access-repathar-nearly-60-savings-2025-10-06</guid>
<pubDate>Mon, 06 Oct 2025 04:00:00 GMT</pubDate>
<description>The collaboration with Amgen reduces out-of-pocket costs for patients and expands access to an innovative cholesterol-lowering therapy SANTA MONICA,</description>
</item>
</channel>
</rss>